Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features

Blood

Volumn 93, Issue 4, 1999, Pages 1372-1380

  Cuneo, Antonio ^a   Bigoni, Renato ^b   Rigolin, Gian Matteo ^b   Roberti, Maria Grazia ^b   Bardi, Antonella ^b   Piva, Nadia ^b   Milani, Raffaella ^b   Bullrich, Florencia ^b   Veronese, Maria Luisa ^b   Croce, Carlo ^b   Birg, Françoise ^b   Döhner, Hartmut ^b   Hagemeijer, Anne ^b   Castoldi, Gianluigi ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOME 13Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 13; CORRELATION FUNCTION; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

EID: 0033557577     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.4.1372     Document Type: Article

References (54)

1. Vandenberghe E, De Wolf-Peeters C, Van Den Oord J, Wlodar ska I, Delabie J, Stul M, Thomas J, Michaux JL, Mecuc ci C, Cassiman JJ, Vandenberghe H: Translocation (11;14): A cytogenetic anomaly associated with B cell lymphomas of non-follicle centre cell lineage. J Pathol 163:13, 1991
2. Vaandrager JW, Schuuring E, Zwikstra E, de Boer CJ, Kleiverda KK, van Krieken JHJM, Kluin-Nelemans HC, van Ommen GJB, Raap AK, Kluin PM: Direct visualization of dispersed 11q13 chromosomal traslocations in mantle cell lymphoma by multi-color DNA fiber FISH. Blood 88:1177, 1996
3. Bigoni R, Negrini M, Veronese ML, Cuneo A, Castoldi G, Croce CM: Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization. Oncogene 13:797, 1996
4. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zuhlke-Jenisch R, Plendl H, Metzke S, Joos S, Zucca E, Weber-Matthiesen K, Roggero E, Grote W, Schlegelberger B: Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Annals Oncol 9:519, 1998
5. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM: Molecular cloning of the chromosomal breakpoint of B cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1043, 1984
6. Rosenberg CL, Wong E, Petty EM, Bale ARE, Tsujimoto Y, Harris NL, Arnold A: PRAD1, a candidate bell oncogene: Mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88:9638, 1991
7. Rimoch R, Berger F, Delsol G, Charrin C, Bertheas MF, Ffrench M, Garoscio M, Felman P, Coiffier B, Bryon PA, Rochet M, Gentilhomme O, Germain D, Magaud JP: Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood 81:3063, 1993
8. Weisenburger DD, Kim H, Rappaport H: Mantle-zone lymphoma. A follicular variant of intermediate lymphocytic lymphoma. Cancer 49:1429, 1982
9. Weisenburger DD, Armitage JO: Mantle Cell Lymphoma - An Entity Comes of Age. Blood 87:4483, 1996
10. Pombo De Oliveira MS, Jaffe ES, Catovsky D: Leukaemic phase of mantle zone (intermediate) lymphoma. Its characterisation in 11 cases. J Clin Pathol 42:962, 1989
11. Raffeld M, Jaffe ES: Bcl-1, t(11;14), and mantle cell derived lymphomas. Blood 78:259, 1991
12. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD: Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood 89:2067, 1996
13. Vandenberghe E, De Wolf-Peeters C, Vaughan Hudson G, Vaughan Hudson B, Pittaluga S, Anderson L, Linch DC: The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group. Br J Haematol 99:842, 1997
14. Zucca E, Stein H, Coiffier B: European Lymphoma Task Force (ELTF) report of the Workshop on mantle cell lymphoma (MCL). Ann Oncol 5:507, 1994
15. Bertini M, Rus C, Freilone R, Botto B, Calvi R, Novero D, Orsucci L, Vitolo U, Palestro G, Resegotti L: Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history. Haematologica 83:312, 1998
16. Bosch F, Lòpez-Guillermo A, Campo E, Ribera JM, Conde E, Piris MA, Vallespì T, Woessner S, Montserrat E: Mantle cell lymphoma. Presenting features, response to therapy, and prognostic factors. Cancer 82:567, 1998
17. Norton AJ, Matthews J, Pappa V, Shamash J, Rohatiner AZS, Lister TA: Mantle cell lymphoma: Natural history defined in a serially biopsied population over 20-year period. Ann Oncol 6:249, 1995
18. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Amesen M: Multiple recurrent genomic defects in follicular lymphoma: A possible model for cancer. N Engl J Med 316:79, 1987
19. Offitt K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Landanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK: Rearrangement of BCL-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74, 1994
20. Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C: Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood, 84: 1043, 1994
21. Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VVVS, Schluger A, Chaganti RSK: p53 overexpression as a marker of poor prognosis in mantle cell lymphoma with t(11;14)(q13;q32). Blood 86:2892, 1995
22. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pedersen A, Anderson JR, Weisenburger DD: p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 87:4302, 1996
23. Döhner H, Fisher K, Bentz M, Hansen K., Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hustein W, Lichter P: p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85:1580, 1995
24. Cabanillas F, Pathak S, Grant G, Hagermeister FB, McLaughlin P, Swan F, Rodriguez MA, Trujillo J, Cork A, Butler JJ, Katz R, Bourne S, Freireich EJ: Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. Am J Med 87:167, 1989
25. Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD: Cytogenetic abnormalities predict clinical outcome in non-Hodgkin's lymphoma. Ann Intern Med 108:14, 1988
26. Offitt K, Wong G, Philippa DA, Tao Y, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508, 1991
27. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P: 11q deletions define a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89:2516, 1997
28. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361, 1994
29. Pittaluga S, Wlodarska I, Stul MS, Thomas J, Verhoef G, Cassiman JJ, Van Den Berghe H, De Wolf-Peeters C: Mantle cell lymphoma: A clinicopathologic study of 55 cases. Histopathology 26:17, 1995
30. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C, The French-American-British (FAB) Cooperative Group: Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 42:567, 1989
31. Cuneo A, Balboni M, Piva N, Rigolin GM, Roberti MG, Mejak C, Moretti S, Bigoni R, Balsamo R, Cavazzini PL, Castoldi GL: Atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32). Karyotype evolution and prolymphocy tic tranformation. Br J Haematol 90:409, 1995
32. Leroux D, Le Marc' hardour F, Gressin R, Jacob MC, Keddari E, Monteil M, Caillot P, Jalbert P, Sotto JJ: Non Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone/intermediate lymphocytic limphoma. Br J Haematol 77:346, 1991
33. Mitelman F (ed). ISCN (1991). Guidelines for cancer cytogenetics. Supplement to an international system for human cytogenetic nomenclature. Basel, Switzerland, Karger, 1995
34. Cuneo A, Bigoni R, Negrini M, Bullrich F, Veronese ML, Roberti MG, Bardi A, Rigolin GM, Cavazzini PL, Croce CM, Castoldi GL: Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carryng BCL1 translocation. Cancer Res 57:1144, 1997
35. Szepetowsky P, Perucca-Lostanlen D, Grosgeorge J, LePaslier D, Brownstein BH, Carle GF, Gaudray P: Description of a 700-kb yeast artificial chromosome contig containing the bcl-1 translocation breakpoint region at 11q13. Cytogenet Cell Genet 69:101, 1995
36. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed J, Croce CM: Minimal region of loss at 13q14 in B-CLL. Blood 88:3109, 1996
37. Hiddemann W: Mantle cell lymphoma. Educational session, Congress of the ISH/EHA, Amsterdam 4-9 July, 1998, pp 125-128.
38. Johansson B, Mertens F, Mitelman F: Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86:3905, 1995
39. Coignet LJA, Schuuring E, Kibbelaar RE, Raap TK, Kleiverda KK, Berthes MF, Wiegant J, Beverstock G, Kluin P: Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. Blood 87:1512, 1996
40. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, Parker A, Castoldi GL, Cuneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720, 1990
41. Cuneo A, Wlodarska I, Sayed Aly M, Piva N, Carli MG, Fagioli F, Tallarico A, Pazzi I, Ferrari L, Cassiman JJ, Van Den Berghe H, Castoldi GL: Nonradioactive in situ hybridization for the detection and monitoring of trisomy 12 in B cell chronic lymphocytic leukaemia. Br J Haematol 81:192, 1992
42. Que TH, Marco JG, Ellis J, Matutes E, Babapulle VB, Boyle S, Catovsky D: Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology. Blood 82:571, 1993
43. Bigoni R, Cuneo A, Roberti MG, Bardi A, Rigolin GM, Piva N, Scapoli G, Spanedda R, Negrini M, Bullrich F, Veronese ML, Croce CM, Castoldi G: Chromosome aberrations in chronic lymphocytic leukemia mixed cell type. A cytogenetic and interphase cytogenetic study. Leukemia 11:1933, 1997
44. Bentz M, Werner CA, Döhner H, Joos S, Barth TFE, Siebert R, Schroder M, Stilgenbauer S, Fischer K, Moller P, Lichter P: High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 88:1437, 1996
45. Avet-Loiseau H, Vigier M, Moreau A, Mellerin MP, Gaillard F, Harousseau JL, Bataille R, Milpied N: Comparative genomic hybridization detects genomic abnormalities in 80% of follicular lymphomas. Br J Haematol 97:119, 1997
46. Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodarska I, Michaux L, Dehaen M, Verhoef G, Thomas J, de Kelver W, Bakker-Shut T, Cassiman JJ, Raap AK, De Wolf-Peeters C, Van den Berghe H, Hagemeijer A: Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia 11:747, 1997
47. Corcoran MM, Rasool O, Liu Y, Iyengar A, Grander D, Ibbotson RE, Merup M, Wu X, Brodyansky V, Gardiner AC, Juliusson G, Chapman RM, Ivanova G, Tiller M, Gahrton G, Yankovsky N, Zabarovsky E, Oscier DG, Eihorn S: Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91:1382, 1998
48. Stilgenbauer S, Nickolenko J, Wilhelm J, Wolf S, Weitz S, Fisher K, Boehm T, Döhner H, Lichter P: Expressed sequences as candidates for a novel tumor suppressor gene at abnd 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16:1891, 1998
49. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, Rasool O, Juiusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Soderhall S, Yankovsky N, Zabarovsky E, Einhorn S: 13q deletions in lymphoid malignancies. Blood 86:1911, 1995
50. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole D, Naucke S, Sawyer J: Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250, 1995
51. Seong C, Delasalle K, Hayes K, Weber D, Dimopoulos M, Swantkowski J, Huh Y, Glassman A, Champlin R, Alexanian R: Prognostic value of cytogenetics in multiple myeloma. Br J Haematol 101:189, 1998
52. Clodi K, Younes A, Goodacre A, Roberts M, Palmer J, Younes M, Cabanillas F, Andeeff M: Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridation. Br J Haematol 98:913, 1997
53. Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Muller-Hermelink Hk, Bentz M, Hiddemann W, Dohner H: Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res 57:4608, 1997
54. Tahara H, Smith AP, Gaz AD, Zariwala M, Xiong Y, Arnold A: Parathyroid tumor suppressor on Ip: analysis of the p18 cyclin-dependent kinase inhibitor gene as a candidate. J Bone Miner Res 12:1330, 1997